iXCells developed a set of bioassays based on patient-derived iPSCs and a variety of primary cells. These highly relevant models, which represent in vivo-like state, are optimized for high-throughput cytotoxicity and viability assays. Our services can be flexibly tailored to your needs with free consultation. To order custom toxicity assays, please contact us.